Dr. Sherron Jackson, a specialist in pediatric hematology/oncology, discusses the treatment of sickle cell disease, including the bone marrow transplant cure. She explains that while bone marrow from a matched sibling donor serves as a cure for sickle cell disease, few patients actually have matched donor siblings. She then talks about hydroxyurea medication as a treatment for symptoms of sickle cell disease. Dr. Jackson mentions hydroxyurea research being performed at MUSC and provides information on how to become part of this clinical research.

For more information on hydroxyurea research, please call the MUSC Sickle Cell Disease clinic at (843)-876-0444.